Literature DB >> 4114014

2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.

H Arnesen, M K Fagerhol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114014     DOI： 10.3109/00365517209080240

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  4 in total

1.  Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

Authors:  P C Harpel; M W Mosesson
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

2.  Impaired mononuclear phagocyte function in patients with severe acute pancreatitis: evidence from studies of plasma clearance of trypsin and monocyte phagocytosis.

Authors:  M Larvin; D J Alexander; S F Switala; M J McMahon
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

3.  Complex-formation and inhibition of urokinase by blood plasma proteins.

Authors:  E K Waller; W D Schleuning; E Reich
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

4.  The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

Authors:  N Aoki; M Moroi; M Matsuda; K Tachiya
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.